Stock Events

Stock Events

Precipio 

€4.96
0
-€0.00-0% Tuesday 20:00

Statistics

Day High
-
Day Low
-
52W High
4.96
52W Low
4.96
Volume
-
Avg. Volume
0
Mkt Cap
8.88M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16NovExpected
Q3 2025
Q1 2026
Q2 2026
Next
-0.04
0.29
0.62
0.96
Expected EPS
N/A
Actual EPS
N/A

Financials

-1.79%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
20.83MRevenue
-373,308.69Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TGK.STU. It's not an investment recommendation.
Fuelcell Energy
8
FCEL
Microsoft
7
MSFT
Tesla
7
TSLA
Amazon
7
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap21.67B
Guardant Health offers liquid biopsy tests similar to Precipio's diagnostic solutions, competing in the cancer diagnostics market.
Fulgent Genetics
FLGT
Mkt Cap539.57M
Fulgent Genetics provides comprehensive genetic testing, competing with Precipio in the genomic diagnostics space.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific offers a wide range of diagnostics and research products, indirectly competing with Precipio's diagnostic services.
Illumina
ILMN
Mkt Cap32.55B
Illumina provides genomic sequencing services and solutions, competing in the genomics space against Precipio.
Qiagen NV
QGEN
Mkt Cap8.9B
Qiagen offers sample and assay technologies for molecular diagnostics, competing with Precipio in the diagnostics market.

About

Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Show more...
CEO
Ilan Danieli
Employees
71
Country
United States
ISIN
US74019L6020
WKN
000A3ETCE

Listings

MU
DE
TGKP.MU
STU
DE
TGK.STU
MU
DE
TGK.MU
STU
DE
TGKP.STU

0 Comments

Share your thoughts

FAQ

What is Precipio stock price today?▼
The current price of TGK.STU is €4.96 EUR — it has decreased by -0% in the past 24 hours. Watch Precipio stock price performance more closely on the chart.
What is Precipio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Precipio stocks are traded under the ticker TGK.STU.
Is Precipio stock price growing?▼
TGK.STU stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Precipio has showed a +0% increase.
What is Precipio market cap?▼
Today Precipio has the market capitalization of 8.88M
When is the next Precipio earnings date?▼
Precipio is going to release the next earnings report on November 16, 2026.
What is Precipio revenue for the last year?▼
Precipio revenue for the last year amounts to 20.83M EUR.
What is Precipio net income for the last year?▼
TGK.STU net income for the last year is -373,308.69 EUR.
How many employees does Precipio have?▼
As of September 04, 2026, the company has 71 employees.
In which sector is Precipio located?▼
Precipio operates in the Health & Wellness sector.
When did Precipio complete a stock split?▼
The last stock split for Precipio was on September 22, 2023 with a ratio of 1:20.
Where is Precipio headquartered?▼
Precipio is headquartered in NEW HAVEN, United States.